Can Ganciclovir be Replaced with Valganciclovir as a Preemptive Therapy for Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantu (HSCT) Recipients?

被引：0
|
作者：
Sachdev, M. [1 ]
Chakraborty, S. [1 ]
Bansal, M. [1 ]
Dua, V. [1 ]
机构：
[1] Fortis Mem Res Inst, Pediat Hematol Oncol Bmt, Gurugram, India
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O0149
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [31] PREEMPTIVE GANCICLOVIR THERAPY IN CYTOMEGALOVIRUS-SEROPOSITIVE RENAL-TRANSPLANTS RECIPIENTS
    CONTI, DJ
    FREED, BM
    SINGH, TP
    GALLICHIO, M
    GRUBER, SA
    LEMPERT, N
    ARCHIVES OF SURGERY, 1995, 130 (11) : 1217 - 1222
  • [32] Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients
    Monforte, V
    Román, A
    Gavaldà, J
    Bravo, C
    Gispert, P
    Pahissa, A
    Morell, F
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 4039 - 4042
  • [33] Efficacy preemptive therapy with ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients
    López-Medrano, F
    Lumbreras, C
    Otero, JR
    González-Alegre, MT
    Juan, RS
    Folgueira, D
    Lizasoaín, M
    Loinaz, C
    Moreno, E
    Aguado, JM
    MEDICINA CLINICA, 2004, 122 (02): : 41 - 45
  • [34] Valganciclovir is effective in the preemptive treatment of cytomegalovirus (CMV) infection after allogeneic stem cell transplant (ASCT)
    Aberle, MF
    Bachier, C
    Lemaistre, FC
    Shaughnessy, PJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 136 - 136
  • [35] A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients
    Mattes, FM
    Hainsworth, EG
    Geretti, AM
    Nebbia, G
    Prentice, G
    Potter, M
    Burroughs, AK
    Sweny, P
    Walker, AFH
    Okwuadi, S
    Sabin, C
    Amooty, G
    Brown, VS
    Grace, SC
    Emery, VC
    Griffiths, PD
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08): : 1355 - 1361
  • [36] High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy
    Limaye, AP
    Raghu, G
    Koelle, DM
    Ferrenberg, J
    Huang, ML
    Boeckh, M
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (01): : 20 - 27
  • [37] Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Silva, Fernando
    Martins, Antonio
    Ferraz, Paula
    Lopes, Diogo
    Bastos, Juliana
    Araujo, Joana
    Trigo, Fernanda
    Pinto, Ricardo
    Silva-pinto, Andre
    ACTA MEDICA PORTUGUESA, 2024, 37 (10) : 733 - 740
  • [38] Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients
    Ishi, Keiko
    Onishi, Yasushi
    Miyamura, Namiko
    Fukuhara, Noriko
    Ishizawa, Kenichi
    Nakanishi, Mutsumi
    Ohnaka, Satoru
    Miyasaka, Tomomitsu
    Kanno, Emi
    Kawakami, Kazuyoshi
    Harigae, Hideo
    Kaku, Mitsuo
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) : 1265 - 1273
  • [39] Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
    Reed, Daniel R.
    Alfaraj, Abeer
    Petroni, Gina
    Monson, Sandra
    Williams, Paige
    DeGregory, Kathlene
    Volodin, Leonid
    Kindwall-Keller, Tamila L.
    Ballen, Karen K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [40] Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts
    Singh, Nina
    Wannstedt, Cheryl
    Keyes, Lois
    Mayher, Debra
    Tickerhoof, Lisa
    Akoad, Mohamed
    Wagener, Marilyn M.
    Cacciarelli, Thomas V.
    LIVER TRANSPLANTATION, 2008, 14 (02) : 240 - 244
12345